株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

アフェレーシス装置の世界市場

Apheresis Equipment

発行 Global Industry Analysts, Inc. 商品コード 222478
出版日 ページ情報 英文 204 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
アフェレーシス装置の世界市場 Apheresis Equipment
出版日: 2019年03月01日 ページ情報: 英文 204 Pages
概要

当レポートでは、世界のアフェレーシス装置市場について調査し、アフェレーシスの概要と技術概要、製品開発動向、今後の見通しとともに、地域別動向、企業プロファイルなどをまとめています。

第1章 イントロダクション、調査方法、製品定義

第2章 エグゼクティブサマリー

  • 序論
    • ドナーアフェレーシス
    • 治療用アフェレーシスが大きく成長
    • 先進国がリードするも将来的には途上国が取って代わる
    • バイオ医薬品企業からの血漿需要増大
    • 採血需要の持続的拡大がアフェレーシス装置市場にとって明るい見通し
    • 競合環境 他
  • 主な市場動向と促進因子
    • 癌発症率の上昇がアフェレーシス処置件数を促進
    • 技術的進歩と新たな適応が市場を拡大
    • 開腹手術における自動血液処理システム
    • 医療費拡大が需要を促進
    • 高齢化:成長牽引因子
    • 主な課題と問題
    • 患者の認識不足が市場成長を阻害 他
  • 技術概要
    • 定義
    • アフェレーシスと全採血
    • アフェレーシスの工程
    • 血液組成
    • アフェレーシス手順
    • アフェレーシスの期間、頻度、効率 他
    • 統合:主な動向
  • 血液組成と派生物
  • 製品開発/認可
  • 近年の業界活動
  • 主要企業
    • 旭化成メディカル株式会社
    • B Braun Melsungen AG
    • Cerus Corporation
    • Fresenius Kabi
    • Fenwal, Inc.
    • Haemonetics Corporation
    • HemaCare Corp.
    • 株式会社カネカ
    • 川澄化学工業株式会社
    • Medica SpA
    • NIKKISO Europe GmbH
    • Terumo BCT, Inc.
    • Therakos, Inc.
  • 世界市場見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
    • フランス
    • ドイツ
    • イタリア
    • 英国
    • スペイン
  • アジア太平洋地域
    • オーストラリア
    • 中国
  • その他の諸国
目次
Product Code: MCP-1237

This report analyzes the worldwide markets for Apheresis Equipment in US$ Thousand by the following Types: Equipment for Therapeutic Apheresis, and Equipment for Donor Apheresis. The Global market is additionally analyzed by the following Procedures: Photopheresis, Plasmapheresis, and Others. Further, the US market is analyzed by the following Therapeutic Areas: Neurology, Hematology & Oncology, Rheumatology, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 14 companies including many key and niche players such as -

Asahi Kasei Medical Co., Ltd.
B Braun Melsungen AG
Cerus Corporation
Fresenius Kabi AG
Haemonetics Corporation
Kaneka Corporation

Table of Contents

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Data Interpretation & Reporting Level
  • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
  • Apheresis Equipment
    • Donor Apheresis Equipment
    • Therapeutic Apheresis Equipment
  • Apheresis Procedures
    • Photopheresis
    • Plasmapheresis
    • LDL-Apheresis (Lipidpheresis)
    • Plateletpheresis
    • Erythrocytapheresis
    • Leukapheresis

2. INDUSTRY OVERVIEW

  • Apheresis Equipment: An Introductory Prelude
  • Bright Prospects Ahead for Apheresis Equipment Market
  • Developed Regions: Primary Revenue Contributors
    • Table 1: Developed Regions account for nearly 3/4th Share of World Apheresis Equipment Market (2019E & 2024P): Percentage Breakdown of Dollar Sales for Developed and Developing Regions (includes corresponding Graph/Chart)
  • Fast Paced Growth Projected in Developing Regions
    • Table 2: Global Apheresis Equipment Market - Geographic Regions Ranked by Value CAGR for 2016-2024: Asia-Pacific, Rest of World, Europe, US, Canada, and Japan (includes corresponding Graph/Chart)
  • Northbound Trajectory in Healthcare Expenditure Creates Fertile Environment
    • Table 3: World Healthcare Spending & Growth (in US$ Trillion) and % Real GDP Growth for the Years 2012 Through 2018E (includes corresponding Graph/Chart)
    • Table 4: Healthcare Spending as % of GDP by Geographic Region (2016) (includes corresponding Graph/Chart)
    • Table 5: Per Capita Healthcare Spending (in US$) in Select Countries for the Year 2016 (includes corresponding Graph/Chart)
  • Sustained Increase in Blood & Plasma Collection Programs Instigates Substantial Opportunities
    • Table 6: Blood Components and Plasma Consumption (in '000 Units) for US, Europe, Japan and Rest of World (2016, 2019E & 2022P) (includes corresponding Graph/Chart)
    • Table 7: Red Blood Cells Consumption (in '000 Units) for US, Europe, Japan, and Rest of World (2016, 2019E & 2022P) (includes corresponding Graph/Chart)
    • Table 8: Total Blood Collections (2016): Percentage Breakdown of Collections (Units) for Leukoreduced and Non-Leukoreduced Blood (includes corresponding Graph/Chart)
  • Blood Supply Shortage & Safety Concerns Promote New Demand
  • Critical Importance of Plasma-Based Products in Diagnostic & Therapeutic Applications Builds Momentum
  • Resolving Prevailing Issues & Challenges: Critical for Future Success
  • Expensive Nature of Apheresis Therapy
  • Lack of Awareness among Patients
  • Shortage of Qualified Donors
  • Less Emphasis on Developing and Promoting High-Tech Equipment

3. KEY MARKET TRENDS & DRIVERS

  • Plasmapheresis: The Primary Procedure Type
    • Table 9: Plasmapheresis Accounts for About Half of World Apheresis Equipment Sales: Percentage Breakdown of Dollar Sales for Plasmapheresis and Other Procedures (2019E& 2024P) (includes corresponding Graph/Chart)
  • Off-Label Indications Widen Adoption of Photopheresis Procedure
  • Plateletpheresis Extends a Handy Tool for Dealing with Bleeding Disorders in Surgeries
  • Increase in Number of Platelet Donors Drives Apheresis Procedures
  • Donor Apheresis: Dominant Equipment Category
    • Table 10: Percentage (%) Share of Donor Apheresis Equipment in the Worldwide Apheresis Equipment Sales (2019E & 2024P) (includes corresponding Graph/Chart)
    • Table 11: Global Blood Donations by Region - Breakdown by Whole Blood Donations and Apheresis Donations for 2013 (Historical Data) (includes corresponding Graph/Chart)
    • Table 12: Global Blood Donations - Apheresis Donation as % of Total Blood Donation by Geographic Region (includes corresponding Graph/Chart)
  • Therapeutic Apheresis Equipment to Witness Strong Growth
  • Disposable Apheresis Kits Market Benefits from Single-Use Nature of Products
  • Centrifugation Technology Continues to Lead, Membrane Filtration Promises Growth
  • Neurology - The Major Application Area for Apheresis Equipment
  • Technological Advancements and Novel Indications Augur Well
  • Innovations in Hybrid Devices Gather Steam
  • Pediatrics: An Unexplored Domain in Therapeutic Apheresis
  • Challenges for Therapeutic Apheresis in Pediatrics Segment
  • Automated Blood Processing Systems in Open Heart Surgeries
  • CFA - An Effective Way to Pull Up Cold Hemagglutinin Disease
  • Rising Cancer Incidence to Drive Volume of Apheresis Procedures
    • Table 13: Worldwide Incidence of Cancer (2010, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart)
    • Table 14: Global Cancer Incidence (2015): Number of New Cancer Cases in Thousands by Type and Gender (includes corresponding Graph/Chart)
    • Table 15: Global Cancer Mortality (2015): Number of Cancer Related Deaths in Thousands by Type and Gender (includes corresponding Graph/Chart)
  • Aging Population: A Strong Growth Driver
    • Table 16: Global Aging Population in Select Regions/Countries: Population of 60+ Individuals in '000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)
    • Table 17: Life Expectancy at Birth (in Years) in Select Countries for 2016 (includes corresponding Graph/Chart)

4. TECHNOLOGY OVERVIEW

  • Apheresis - The Definition
  • Apheresis Vs. Whole Blood Collection
  • Comparison of Apheresis and Whole Blood Collection
  • The Process of Apheresis - An Overview
  • Apheresis Procedure
  • Duration, Frequency, and Efficiency of Apheresis
  • Segregation of Blood Components
  • Centrifugation
  • Centrifugal Cell Separators
  • Filtration
  • Side Effects
  • Types of Apheresis Procedures
  • Photopheresis
    • Functioning of THERAKOS(tm) - A Typical Photopheresis System
  • Plasmapheresis
    • Facts About Plasma and its Donation
    • Pre-requisites for Plasma Donors
    • The Complex Process of Becoming a Donor
    • Medical Screening
    • The Process of Plasma Donation
    • Sources of Blood Plasma
    • Plasma Exchange and Plasmapheresis: The Difference
    • Therapeutic Plasma Exchange (TPE) or Plasma Exchange
      • TPE: Abnormal Components Removed from Blood
    • Plasmapheresis: Potential Uses Discovered in the Early Years
      • Potential Use of Plasmapheresis in Select Diseases Discovered in the Early Years
  • Erythrocytapheresis
  • Plateletpheresis
  • Leukapheresis
  • LDL-Apheresis (Lipidpheresis)
  • Cytapheresis
  • Stem Cell Collection
  • Types of Apheresis Equipment
  • Donor Apheresis
    • Process of Donor Apheresis
    • Automated Blood Donation Procedures
    • Safety of the Donor
      • Blood Components Required by Different Patients
  • Therapeutic Apheresis: An Introduction
    • Therapeutic Apheresis Techniques
    • Applications of Therapeutic Apheresis
      • Categories of Indications for Therapeutic Apheresis
      • Therapeutic Apheresis is Remedial for Various Diseases
      • Indications for Therapeutic Apheresis
      • Type of Therapeutic Apheresis Procedure Used in Different Medication Conditions
      • Emerging Applications of Therapeutic Apheresis
    • Cost of Select Therapeutic Apheresis Procedures: An Overview
      • 1. Photopheresis in GvHD (Graft-Versus- Host Disease)
      • 2. Lipid Apheresis (LDL Apheresis)
      • 3. Plasmapheresis and Other Procedures
    • Therapeutic Apheresis: What is the Risk Involved?
    • Replacement Fluid in Therapeutic Apheresis
      • Replacement Fluids Used in Therapeutic Apheresis
      • Various Replacement Fluids in Use
      • Select Replacement Fluids and their Limitations
    • Table 18: Fluid Balance in Fluid Replacement
    • Table 19: Volume Exchange of Plasma Constituents (includes corresponding Graph/Chart)
    • Table 20: Removal of IgM and IgG by Plasma Exchange Volume (includes corresponding Graph/Chart)
    • Table 21: Therapeutic Apheresis: Percentage Decrease and Restoration of Blood Components
      • Complications Involved and Suggested Treatment in the Therapeutic Apheresis Procedure
    • Therapeutic Plasmapheresis with Fresh Frozen Plasma (FFP) Replacement

5. BLOOD COMPONENTS & DERIVATIVES

  • Blood: The Circulating Tissue of Human Body
  • Ionic Composition of Blood
  • Types of Blood
  • General Facts about Blood
  • General Uses of Blood
  • Blood - Global Facts
  • Components of Blood
  • Red Blood Cells (RBCs)
  • White Blood Cells (WBCs)
  • Platelets
  • Plasma

6. COMPETITIVE LANDSCAPE

  • Fresenius Kabi, Haemonetics and Terumo BCT: Dominant Vendors of Apheresis Equipment
    • Table 22: Leading Players in the Global Apheresis Systems Market (2018E): Percentage Breakdown of Value Sales for Fresenius Kabi, Haemonetics, Terumo BCT and Others (includes corresponding Graph/Chart)
    • Table 23: Leading Players in the Global Blood Component Collection Market (2018E): Percentage Breakdown of Value Sales for Fresenius Kabi, Haemonetics, Terumo BCT and Others (includes corresponding Graph/Chart)
  • Consolidation of Blood Collectors & Healthcare Providers Puts Pricing Pressure on Suppliers
  • 6.1 Focus on Select Global Players
  • Asahi Kasei Medical Co., Ltd. (Japan)
  • B Braun Melsungen AG (Germany)
  • Cerus Corporation (USA)
  • Fresenius Kabi AG (Germany)
  • Haemonetics Corporation (USA)
  • Kaneka Corporation (Japan)
  • Kawasumi Laboratories, Inc. (Japan)
  • Mallinckrodt Pharmaceuticals (Ireland)
  • Medica SpA (Italy)
  • NIKKISO Europe GmbH (Germany)
  • Terumo BCT, Inc. (USA)
  • 6.2 Product Launches/Approvals/Study Results
  • Mallinckrodt Releases Latest Study Results for THERAKOS CELLEX System in Treating aGvHD Pediatric Patients
  • GE Healthcare Life Sciences Unveils Sefia S-2000 Cell Processing System
  • American Red Cross Receives FDA Approval for BLA for Interstate Distribution of Platelets
  • Cerus Receives Health Canada Approval for INTERCEPT Blood System for Platelets
  • Cerus Files for CE Mark Registration for INTERCEPT RBC System
  • Haemonetics Wins FDA Clearance for Enhancement of NexSys PCS(tm) Embedded Software
  • Haemonetics Gains FDA Approval for NexSys PCS Plasmapheresis System
  • Terumo BCT Receives CE Mark for Spectra Optia(r) Apheresis System
  • 6.3 Recent Industry Activity
  • Mallinckrodt Inks Collaboration Agreement with Transimmune
  • Fresenius Kabi UK to Expand Operations in Runcorn, Cheshire
  • Fresenius Kabi Announces Expansion Project at Haina Site in Dominican Republic
  • Fresenius Kabi Opens New Laboratory & Office Areas at Graz Innovation & Development Center
  • Haemonetics to Relocate Global Headquarters to Boston from Braintree, Massachusetts
  • UniCAR-Therapy Teams Up with Terumo BCT
  • Terumo BCT to Establish I&D Centers in India
  • Terumo BCT Collaborates with StafaCT
  • Fresenius Kabi to Build New Ware House at Blonie Site in Poland
  • Haemonetics Renames Shanghai Subsidiary as Haemonetics (Shanghai) Management Co., Ltd.

7. GLOBAL MARKET PERSPECTIVE

    • Table 24: World Recent Past, Current & Future Analysis for Apheresis Equipment by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 25: World Historic Review for Apheresis Equipment by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 26: World 14-Year Perspective for Apheresis Equipment by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
    • Table 27: World Recent Past, Current & Future Analysis for Equipment for Therapeutic Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 28: World Historic Review for Equipment for Therapeutic Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 29: World 14-Year Perspective for Equipment for Therapeutic Apheresis by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
    • Table 30: World Recent Past, Current & Future Analysis for Equipment for Donor Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 31: World Historic Review for Equipment for Donor Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 32: World 14-Year Perspective for Equipment for Donor Apheresis by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
    • Table 33: World Recent Past, Current & Future Analysis for Apheresis Equipment by Procedure Type - Photopheresis, Plasmapheresis, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 34: World Historic Review for Apheresis Equipment by Procedure Type - Photopheresis, Plasmapheresis, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 35: World 14-Year Perspective for Apheresis Equipment by Procedure Type - Percentage Breakdown of Dollar Sales for Photopheresis, Plasmapheresis, and Others Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)

8. REGIONAL MARKET PERSPECTIVE

  • 8.1 The United States
  • A. Market Analysis
    • The United States: Most Important Market for Apheresis Equipment
    • Table 36: Percentage (%) Share of the US in the Worldwide Apheresis Equipment Sales (2019E & 2024P) (includes corresponding Graph/Chart)
    • While Donor Apheresis Equipment Remains Largest Segment, Therapeutic Segment Registers Strong Growth
    • Growing Demand for Plasma-based Therapies Fuels Adoption of Plasmapheresis Devices
    • Blood & Plasma Donations in the US
      • Blood Donations
    • Table 37: Blood Transfusions per 1000 population in the US (2012-2017) (includes corresponding Graph/Chart)
    • Table 38: Blood Donation in the US (2016): Percentage Breakdown of Number of Blood Donations by Type - Apheresis Donation and Whole Blood Donation (includes corresponding Graph/Chart)
      • Blood Supply and Demand in the US - A Fact Sheet
      • Criteria for Platelet Donation
      • Criteria for Double Red Cell Donation
      • Plasma Donations
    • Table 39: Plasma Collection in the US for 2012, 2014 & 2016 (in Million Liters) (includes corresponding Graph/Chart)
      • Select IQPP-authorized Plasma Collection Centers in the US
    • Competitive Scenario
    • Table 40: Leading Players in the US Whole Blood Collection Market (2018E): Percentage Breakdown of Volume Sales for Fresenius Kabi, Haemonetics, Terumo BCT and Others (includes corresponding Graph/Chart)
    • Table 41: Leading Players in the US Market for Therapeutic Apheresis in Neurological Disorders (2018E): Percentage Breakdown of Revenues for Fresenius Kabi, Haemonetics, Terumo BCT, and Others (includes corresponding Graph/Chart)
    • Table 42: Leading Players in the US Market for Therapeutic Apheresis in Hematology and Oncology Disorders (2018E): Percentage Breakdown of Revenues for Fresenius Kabi, Terumo BCT, and Others (includes corresponding Graph/Chart)
      • Consolidation of Blood Collectors and Healthcare Providers Puts Pricing Pressure on Suppliers
    • An Overview of Regulatory Environment and Reimbursement Scenario
      • Reimbursement Policies to Create Growth Opportunities for Therapeutic Apheresis
      • Medicaid Coverage for Therapeutic Apheresis by Various Conditions
      • Medicaid Coverage for Therapeutic Plasma Exchange
    • Table 43: Payment Rates for Apheresis Procedures in 2016 & 2017 (In US$) (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 44: US Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 45: US Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 46: US 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
    • Table 47: US Recent Past, Current & Future Analysis for Apheresis Equipment by Therapeutic Area - Neurology, Hematology & Oncology, Rheumatology and Others Therapeutic Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 48: US Historic Review for Apheresis Equipment by Therapeutic Area - Neurology, Hematology & Oncology, Rheumatology and Others Therapeutic Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 49: US 14-Year Perspective for Apheresis Equipment by Therapeutic Area - Percentage Breakdown of Dollar Sales for Neurology, Hematology & Oncology, Rheumatology and Others Therapeutic Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
  • 8.2 Canada
  • Market Analysis
    • Table 50: Canadian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 51: Canadian Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 52: Canadian 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
  • 8.3 Japan
  • A. Market Analysis
    • Therapeutic Apheresis Market - An Overview
    • Growing Demand for Cancer Treatments Drives Plateletpheresis Market
  • B. Market Analytics
    • Table 53: Japanese Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 54: Japanese Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 55: Japanese 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
  • 8.4 Europe
  • A. Market Analysis
    • Europe Remains a Primary Market for Apheresis Equipment
    • Blood Banks Scenario in Europe
    • Table 56: Leading Players in the European Whole Blood Collection Market (2018E): Percentage Breakdown of Volume Sales for Fresenius Kabi, MacoPharma, Terumo BCT and Others (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 57: European Recent Past, Current & Future Analysis for Apheresis Equipment by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 58: European Historic Review for Apheresis Equipment by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 59: European 14-Year Perspective for Apheresis Equipment by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
    • Table 60: European Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 61: European Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 62: European 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
  • 8.4.1 France
  • Market Analysis
    • Table 63: French Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 64: French Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 65: French 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
  • 8.4.2 Germany
  • Market Analysis
    • Table 66: German Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 67: German Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 68: German 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
  • 8.4.3 Italy
  • Market Analysis
    • Table 69: Italian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 70: Italian Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 71: Italian 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
  • 8.4.4 The United Kingdom
  • Market Analysis
    • Table 72: UK Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 73: UK Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 74: UK 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
  • 8.4.5 Spain
  • Market Analysis
    • Table 75: Spanish Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 76: Spanish Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 77: Spanish 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
  • 8.4.6 Rest of Europe
  • Market Analysis
    • Table 78: Rest of Europe Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 79: Rest of Europe Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 80: Rest of Europe 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
  • 8.5 Asia-Pacific
  • A. Market Analysis
    • Asia-Pacific Emerges as Fastest Growing Market for Apheresis Equipment
    • Key Factors Influencing Demand for Imaging and Other Medical Equipment in Asia-Pacific
      • Soaring Investments on Healthcare Infrastructure
      • Increased Healthcare Awareness Among Population
      • Proliferation of Medical Tourism
  • B. Market Analytics
    • Table 81: Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Geographic Region - Australia, China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 82: Asia-Pacific Historic Review for Apheresis Equipment by Geographic Region - Australia, China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 83: Asia-Pacific 14-Year Perspective for Apheresis Equipment by Geographic Region - Percentage Breakdown of Dollar Sales for Australia, China and Rest of Asia-Pacific Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
    • Table 84: Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 85: Asia-Pacific Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 86: Asia-Pacific 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
  • 8.5.1 Australia
  • Market Analysis
    • Table 87: Australian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 88: Australian Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 89: Australian 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
  • 8.5.2 China
  • Market Analysis
    • Table 90: Chinese Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 91: Chinese Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 92: Chinese 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
  • 8.5.3 Rest of Asia-Pacific
  • Market Analysis
    • Table 93: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 94: Rest of Asia-Pacific Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 95: Rest of Asia-Pacific 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)
  • 8.6 Rest of World
  • Market Analysis
    • Table 96: Rest of World Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 97: Rest of World Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 98: Rest of World 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2019 & 2024 (includes corresponding Graph/Chart)

9. COMPANY PROFILES

  • Total Companies Profiled: 14 (including Divisions/Subsidiaries - 20) The United States (8) Japan (3) Europe (9) - Germany (5) - Italy (3) - Rest of Europe (1)
Back to Top